Somatostatin-Producing Neuroendocrine Tumor

Somatostatin-Producing Neuroendocrine Tumor — Trials · CancerIndex

Clinical trials

Registered studies

17 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02031536	Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery	terminated	Phase 2	2	ECOG-ACRIN Cancer Research GroupNETWORK	1	Jun 29, 2023	clinicaltrials
NCT02273752	Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer	terminated	Phase 2	2	Emory UniversityOTHER	1	Feb 3, 2017	clinicaltrials
NCT00084461	Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors	terminated	Phase 2	25	National Cancer Institute (NCI)NIH	1	Jun 4, 2013	clinicaltrials

Data updated 22 days agoSource updated Jun 29, 2023source: clinicaltrials